Terms: = Breast cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Treatment
120 results:
1. Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/rac1.
Fang H; Ren W; Cui Q; Liang H; Yang C; Liu W; Wang X; Liu X; Shi Y; Feng J; Chen C
Elife; 2023 Oct; 12():. PubMed ID: 37787041
[TBL] [Abstract] [Full Text] [Related]
2. MAP7D3, a novel prognostic marker for triple-negative breast cancer, drives cell invasiveness and cancer-initiating cell properties to promote metastatic progression.
Kuo WH; Chu PY; Wang CC; Huang PS; Chan SH
Biol Direct; 2023 Aug; 18(1):44. PubMed ID: 37550720
[TBL] [Abstract] [Full Text] [Related]
3. The Role of
Géci I; Bober P; Filová E; Amler E; Sabo J
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511111
[TBL] [Abstract] [Full Text] [Related]
4. Anticancer activity of thymoquinone against breast cancer cells: Mechanisms of action and delivery approaches.
Shabani H; Karami MH; Kolour J; Sayyahi Z; Parvin MA; Soghala S; Baghini SS; Mardasi M; Chopani A; Moulavi P; Farkhondeh T; Darroudi M; Kabiri M; Samarghandian S
Biomed Pharmacother; 2023 Sep; 165():114972. PubMed ID: 37481931
[TBL] [Abstract] [Full Text] [Related]
5. Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative breast cancer by Integrated Bioinformatical Analysis.
Han YH; Wang Y; Lee SJ; Mao YY; Jiang P; Sun HN; Jin MH; Kwon T
Anticancer Res; 2023 Jul; 43(7):2951-2964. PubMed ID: 37351977
[TBL] [Abstract] [Full Text] [Related]
6. ARHGAP25 suppresses the development of breast cancer by an ARHGAP25/Wnt/ASCL2 feedback loop.
Han S; Jin X; Hu T; Chi F
Carcinogenesis; 2023 Aug; 44(5):369-382. PubMed ID: 37326327
[TBL] [Abstract] [Full Text] [Related]
7. Synthetic and natural guanidine derivatives as antitumor and antimicrobial agents: A review.
Gomes AR; Varela CL; Pires AS; Tavares-da-Silva EJ; Roleira FMF
Bioorg Chem; 2023 Sep; 138():106600. PubMed ID: 37209561
[TBL] [Abstract] [Full Text] [Related]
8. An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative breast cancer Progression.
Lu XX; Yang WX; Pei YC; Luo H; Li XG; Wang YJ; Zhang GL; Ling H; Shao ZM; Hu X
Cancer Res; 2023 Jun; 83(12):2000-2015. PubMed ID: 37057875
[TBL] [Abstract] [Full Text] [Related]
9. In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells.
Amalina ND; Salsabila IA; Zulfin UM; Jenie RI; Meiyanto E
J Egypt Natl Canc Inst; 2023 Mar; 35(1):6. PubMed ID: 36967442
[TBL] [Abstract] [Full Text] [Related]
10. Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines.
Tawfeeq N; Lazarte JMS; Jin Y; Gregory MD; Lamango NS
Oncotarget; 2023 Mar; 14():243-257. PubMed ID: 36961909
[TBL] [Abstract] [Full Text] [Related]
11. rac1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells.
Chen F; Gurler SB; Novo D; Selli C; Alferez DG; Eroglu S; Pavlou K; Zhang J; Sims AH; Humphreys NE; Adamson A; Campbell A; Sansom OJ; Tournier C; Clarke RB; Brennan K; Streuli CH; Ucar A
Oncogene; 2023 Feb; 42(9):679-692. PubMed ID: 36599922
[TBL] [Abstract] [Full Text] [Related]
12. DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of rac1 to prevent β-catenin nuclear accumulation.
Xiong Z; Yang L; Li N; Fu J; Liu P; Sun P; Wei W; Xie X
Clin Transl Med; 2022 Dec; 12(12):e1133. PubMed ID: 36536485
[TBL] [Abstract] [Full Text] [Related]
13. RAB4A GTPase regulates epithelial-to-mesenchymal transition by modulating rac1 activation.
Karthikeyan S; Casey PJ; Wang M
Breast Cancer Res; 2022 Oct; 24(1):72. PubMed ID: 36307864
[TBL] [Abstract] [Full Text] [Related]
14. PACT promotes the metastasis of basal-like breast cancer through rac1 SUMOylation and activation.
Wei L; Wang W; Yao J; Cui Z; Xu Z; Ding H; Wu X; Wang D; Luo J; Ke ZJ
Oncogene; 2022 Sep; 41(37):4282-4294. PubMed ID: 35974143
[TBL] [Abstract] [Full Text] [Related]
15. LncRNA RP11-214F16.8 drives breast cancer tumorigenesis via a post-translational repression on NISCH expression.
Lv X; Zhang Q
Cell Signal; 2022 Apr; 92():110271. PubMed ID: 35108640
[TBL] [Abstract] [Full Text] [Related]
16. DOCK2 regulates antifungal immunity by regulating RAC GTPase activity.
Ma X; Tan X; Yu B; Sun W; Wang H; Hu H; Du Y; He R; Gao R; Peng Q; Cui Z; Pan T; Feng X; Wang J; Xu C; Zhu B; Liu W; Wang C
Cell Mol Immunol; 2022 May; 19(5):602-618. PubMed ID: 35079145
[TBL] [Abstract] [Full Text] [Related]
17. Co-targeting BET bromodomain BRD4 and rac1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer.
Ali A; Shafarin J; Unnikannan H; Al-Jabi N; Jabal RA; Bajbouj K; Muhammad JS; Hamad M
Int J Biol Sci; 2021; 17(15):4474-4492. PubMed ID: 34803511
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative breast cancer.
Cruz-Collazo A; Ruiz-Calderon JF; Picon H; Borrero-Garcia LD; Lopez I; Castillo-Pichardo L; Del Mar Maldonado M; Duconge J; Medina JI; Bayro MJ; Hernández-O'Farrill E; Vlaar CP; Dharmawardhane S
Mol Cancer Ther; 2021 Dec; 20(12):2420-2432. PubMed ID: 34607932
[TBL] [Abstract] [Full Text] [Related]
19. Optimizing metastatic-cascade-dependent rac1 targeting in breast cancer: Guidance using optical window intravital FRET imaging.
Floerchinger A; Murphy KJ; Latham SL; Warren SC; McCulloch AT; Lee YK; Stoehr J; Mélénec P; Guaman CS; Metcalf XL; Lee V; Zaratzian A; Da Silva A; Tayao M; Rolo S; Phimmachanh M; Sultani G; McDonald L; Mason SM; Ferrari N; Ooms LM; Johnsson AE; Spence HJ; Olson MF; Machesky LM; Sansom OJ; Morton JP; Mitchell CA; Samuel MS; Croucher DR; Welch HCE; Blyth K; Caldon CE; Herrmann D; Anderson KI; Timpson P; Nobis M
Cell Rep; 2021 Sep; 36(11):109689. PubMed ID: 34525350
[TBL] [Abstract] [Full Text] [Related]
20. rac1 plays an essential role in estrogen receptor alpha function in breast cancer cells.
Sun J; Gaidosh G; Xu Y; Mookhtiar A; Man N; Cingaram PR; Blumenthal E; Shiekhattar R; Goka ET; Nimer SD; Lippman ME
Oncogene; 2021 Oct; 40(40):5950-5962. PubMed ID: 34373577
[TBL] [Abstract] [Full Text] [Related]
[Next]
